Gene · 3959
Papers2,653
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,653
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Milk-Derived Extracellular Vesicles and microRNAs: Potential Modulators of Intestinal Homeostasis. | FASEB J | 2025 | 40838537 | PubTator, text mining | PubMed |
| Elucidating the role of LGALS3BP in coronary atherosclerosis: integrating bioinformatics and machine learning for advanced insights. | J Cardiothorac Surg | 2025 | 40814096 | PubTator, text mining | PubMed |
| Decreased β-cell function in a case with Becker muscular dystrophy accompanied by post-transplant diabetes. | Endocrinol Diabetes Metab Case Rep | 2025 | 40803347 | PubTator, text mining | PubMed |
| Astrocyte diversity and subtypes: aligning transcriptomics with multimodal perspectives. | EMBO Rep | 2025 | 40750713 | PubTator, text mining | PubMed |
| Construction of Gene Regulatory Networks Based on Spatial Multi-Omics Data and Application in Tumor-Boundary Analysis. | Genes (Basel) | 2025 | 40725477 | PubTator, text mining | PubMed |
| The P4HB/LGALS3BP/NF-kB axis promotes the progression of MIA to IAC in lung adenocarcinoma. | Sci Rep | 2025 | 40696131 | PubTator, text mining | PubMed |
| Efficacy and Safety of Glecaprevir/Pibrentasvir in Children Aged 3-11 Years With Chronic Hepatitis C: A Real-World, Prospective, Multicenter Study in Japan. | Hepatol Res | 2025 | 40690381 | PubTator, text mining | PubMed |
| Altered glycosylation of EVs in cancers: galectin-3-binding protein (LGALS3BP). | Discov Oncol | 2025 | 40663256 | PubTator, text mining | PubMed |
| Effect of Tirzepatide Treatment on Hepatic Biomarkers in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease and Type 2 Diabetes Mellitus. | Hepatol Res | 2025 | 40616360 | PubTator, text mining | PubMed |
| [Biomarkers selection and prediction of disease progression in tuberculosis patients based on transcriptome expression data]. | Zhonghua Jie He He Hu Xi Za Zhi | 2025 | 40582977 | PubTator, text mining | PubMed |
| Galectin-3-binding protein is a risk factor for diabetes, metabolic syndrome, and inflammation. Cross-sectional and longitudinal results from the InCHIANTI study. | Mech Ageing Dev | 2025 | 40581184 | PubTator, text mining | PubMed |
| ITGAV Regulation of LGALS3BP-JUNB Axis Facilitates the Cell-to-Cell Adhesion and Invasiveness of Hepatic Cancer Cells. | Anticancer Res | 2025 | 40578967 | PubTator, text mining | PubMed |
| Development of a colloidal gold immunochromatographic strip to detect equine infectious anemia virus. | Virol J | 2025 | 40555999 | PubTator, text mining | PubMed |
| LGALS3BP/90K suppresses porcine reproductive and respiratory syndrome virus replication by enhancing GP3 degradation and stimulating innate immunity. | Vet Res | 2025 | 40542445 | PubTator, text mining | PubMed |
| Machine learning-based identification of exosome-related biomarkers and drugs prediction in nasopharyngeal carcinoma. | Discov Oncol | 2025 | 40526256 | PubTator, text mining | PubMed |
| Assessing the role of Mac-2 binding protein glycosylation isomer in the management of patients with chronic hepatitis B. | World J Hepatol | 2025 | 40501477 | PubTator, text mining | PubMed |
| Can mac-2 binding protein glycosylation isomer serve as a biomarker for predicting pulmonary arterial pressure and pulmonary hypertension in systemic sclerosis? | Turk J Med Sci | 2025 | 40342320 | PubTator, text mining | PubMed |
| Plasma protein corona of liposomes loaded with a phospholipid-allocolchicinoid conjugate enhances their anti-inflammatory potential. | Colloids Surf B Biointerfaces | 2025 | 40319730 | PubTator, text mining | PubMed |
| Changes in serum myostatin levels among patients with type C liver cirrhosis treated with direct-acting antivirals. | Hepatol Res | 2025 | 40317867 | PubTator, text mining | PubMed |
| Expression patterns of hepatic Mac2-BP in the liver microenvironment. | Hepatol Res | 2025 | 40317601 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3959/papers?page=6